Clinical Trial Update: Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis [Phase 1, Phase 2]

View source ↗

Summary

This document outlines an ongoing Phase 1/2 clinical trial evaluating Hepzato Kit in combination with Opdualag for metastatic melanoma with liver metastases, cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Melanoma

Drugs mentioned

• HEPZATO KIT (melphalan hydrochloride injection, lyophilized, for solution)
• Opdualag (relatlimab and nivolumab)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Metastatic Melanoma, Liver Metastases | Phase 1, Phase 2 | Status: RECRUITING